Acquired Hemophilia Following Bullous Pemphigoid in an Elderly Patient: A Case Report and Literature Review
MedPeer publisher · 2026
DOI: 10.70780/medpeer.000qgtm ↗Kurz gefasst
Fallbericht in der Zeitschrift MedPeer publisher, 2026. Verfasst von Fatima Zahraa Sassine und 4 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
Acquired hemophilia A (AHA) is a rare autoimmune bleeding disorder caused by autoantibodies directed against coagulation factor VIII, leading to spontaneous or trauma-related hemorrhage. Unlike congenital hemophilia, AHA predominantly affects the elderly and may be associated with autoimmune diseases, malignancies, pregnancy, or medications. Bullous pemphigoid (BP), a subepidermal autoimmune blistering disorder, has been reported as a potential trigger for AHA due to persistent immune dysregulation. We report the case of an 84-year-old woman with a history of bullous pemphigoid treated successfully with topical corticosteroids eight months prior, who presented with a rapidly progressive purpuric plaque and uncontrolled bleeding following minor trauma. Laboratory evaluation revealed isolated prolongation of activated partial thromboplastin time (aPTT: 78 seconds) with normal prothrombin time. Mixing studies failed to correct the aPTT, suggesting the presence of an inhibitor. Further workup confirmed markedly reduced factor VIII activity (1%) and the presence of factor VIII inhibitors (18 Bethesda units), establishing the diagnosis of acquired hemophilia A. The patient was treated with recombinant activated factor VII (rFVIIa) for acute bleeding control and immunosuppressive therapy with prednisone and cyclophosphamide for inhibitor eradication. Complete remission was achieved at 12 weeks, with normalization of factor VIII levels and disappearance of inhibitors. This case highlights the importance of considering acquired hemophilia A in elderly patients presenting with unusual bleeding manifestations, particularly in the context of prior autoimmune disease. The association between bullous pemphigoid and AHA, though rare, underscores the need for vigilance regarding immune-mediated complications in patients with autoimmune blistering disorders.
Zitieren
APA
Sassine, F. Z., Saci, M., Pascaru, O., Aloui, S., & Sanchez, M. (2026). Acquired Hemophilia Following Bullous Pemphigoid in an Elderly Patient: A Case Report and Literature Review. MedPeer publisher. https://doi.org/10.70780/medpeer.000qgtm
Vancouver
Sassine FZ, Saci M, Pascaru O, Aloui S, Sanchez M. Acquired Hemophilia Following Bullous Pemphigoid in an Elderly Patient: A Case Report and Literature Review. MedPeer publisher. 2026. doi:10.70780/medpeer.000qgtm
BibTeX
@article{Sassine2026,
author = {Sassine, Fatima Zahraa and Saci, Méria and Pascaru, Oana and Aloui, Sandra and Sanchez, Michele},
title = {Acquired Hemophilia Following Bullous Pemphigoid in an Elderly Patient: A Case Report and Literature Review},
journal = {MedPeer publisher},
year = {2026},
doi = {10.70780/medpeer.000qgtm}
}
EUVIMED